COMMUNIQUÉS West-GlobeNewswire
      -   
  
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
20/03/2018 -   
  
Orion Corporation: Organising meeting of the Board of Directors
20/03/2018 -   
  
Grant of share options and performance shares to members of the Board of Management and key employees
20/03/2018 -   
  
Konica Minolta’s Exa Platform Helps Green Bay Radiology Grow While Streamlining Operations
20/03/2018 -   
  
BioCorRx Comments on President Donald J. Trump’s Initiative to Stop Opioid Abuse
20/03/2018 -   
  
Orion Corporation: Decisions by the AGM on 20 March 2018
20/03/2018 -   
  
Oxford Performance Materials Receives Japanese Accreditation of Foreign Medical Device Manufacturer
20/03/2018 -   
  
Appeals Court Upholds Exergen Temporal Artery Thermometer Patent Infringement by Helen of Troy’s Braun and Vicks Forehead Thermometers
20/03/2018 -   
  
Profound Medical Corp. Announces Closing of Bought Deal Financing
20/03/2018 -   
  
OncBioMune Announces Presentation at the 2018 AACR Annual Meeting
20/03/2018 -   
  
Lundbeck held its Annual General Meeting on 20 March 2018 at the company’s registered office
20/03/2018 -   
  
Media Advisory - The Heart Institute Officially Inaugurates New State-of-The-(He)Art Facility
20/03/2018 -   
  
Avis aux médias - L'Institut de cardiologie inaugure ses nouvelles installations de pointe
20/03/2018 -   
  
Patient-Friendly Breast Tumor Localization Now Available in Connecticut
20/03/2018 -   
  
The Ensign Group Declares Quarterly Dividend of $0.045 Per Share
20/03/2018 -   
  
NSS Labs to Announce 2018 Advanced Endpoint Protection Group Test Results at RSA Conference in San Francisco
20/03/2018 -   
  
“Spread the AFFECTION not the INFECTION”
20/03/2018 -   
  
Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals
20/03/2018 -   
  
Zealand Pharma's first Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia successfully meets its primary objective
20/03/2018 
Pages